You are here:

AOP Orphan Contact

AOP Orphan worldwide

Wilhelminenstraße 91/IIf
1160 Vienna, Austria


Know How and Passion

Our management team at AOP Orphan is composed of a highly skilled set of experts whose careers and educational background in natural sciences have set them above their peers. They are a clear representation of the competence and professionalism that is found in each of our employees.

Led by a Board of Directors with longstanding experience in the pharmaceutical Industry:

Andreas Steiner, Chief Executive Officer and chairman of the board, an economist by educations brings both inside views from the pharmaceutical industry as well as hospital management,

Dr. Rudolf Widmann, founder of the company, pharmacist by education with deep knowledge and passion for orphan diseases,

Dr. Günther Krumpl, medical doctor, pharmacologist, Associate Professor and entrepreneurial pioneer in the pharmaceutical industry.

The Board Members and the Executive Members, a team of highly educated experts, together form the Executive Management Team.

Most of them graduated in natural science and have acquired extensive research experience from both university institutions and industry research facilities. However, what binds them all together is not their common scientific background but rather their passion for fighting Orphan Diseases.

It is this passion that drives our management team and all our employees to fully commit themselves to developing and producing efficient drugs that can effectively fight Orphan Diseases and enhance the quality of the patient’s life to the greatest extent possible.


Mag. Andreas Steiner

Chief Executive Officer
Chairman of the Board

Dr. Rudolf Widmann

Chief Therapeutics Development Officer
Board Member

Dr. Roland Bindeus

Director Business Unit Hematology & Oncology

Mag. Daniela Gruber

Director Business Unit
Neurology & Psychiatry/Gastroenterology

Dr. Gunther Krumpl

Chief Corporate Development Officer
Board Member

Agnes Kohl

Agnes Kohl, MPharmSc

Head of Business Development

Mag. Petra Lanz

Chief Commercial Officer